Published in Vaccine on July 16, 1999
A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol (2004) 1.25
Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect Immun (2001) 1.21
Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis? Infect Immun (2006) 0.98
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. PLoS Pathog (2017) 0.75
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01
Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet (1982) 3.64
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet (1982) 3.39
Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol (2001) 3.12
P-antigen-recognizing fimbriae from human uropathogenic Escherichia coli strains. Infect Immun (1982) 3.02
Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli. Lancet (1981) 2.76
Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis. Pediatr Clin North Am (1982) 2.33
Bacterial adherence to periurethral epithelial cells in girls prone to urinary-tract infections. Lancet (1978) 2.25
Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol (1999) 2.23
Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun (1979) 2.21
Epidemic outbreaks of acute pyelonephritis caused by nosocomial spread of P fimbriated Escherichia coli in children. J Infect Dis (1984) 2.19
Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods (2001) 2.07
In vitro adhesion of uropathogenic Escherichia coli to human periurethral cells. Infect Immun (1980) 1.98
Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test. Infection (1982) 1.88
Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. Trans R Soc Trop Med Hyg (2001) 1.87
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Eur J Clin Microbiol (1987) 1.72
Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection (1980) 1.66
Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax (1990) 1.65
Carbohydrate receptor structures recognized by uropathogenic E. coli. Scand J Infect Dis Suppl (1982) 1.63
P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection (1983) 1.57
AIDS and Mycobacterium avium serovars in Sweden. Lancet (1989) 1.55
Coupling of acid labile Salmonella specific oligosaccharides to macromolecular carriers. J Immunol Methods (1979) 1.52
Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis (2001) 1.47
Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau. J Clin Microbiol (1993) 1.47
Urinary tract infections treated with single dose of short-acting sulphonamide. Br Med J (1979) 1.41
Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect Immun (1981) 1.38
Receptors for pyelonephritogenic Escherichia coli in primates. J Urol (1984) 1.34
Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis (1994) 1.33
Molecular epidemiological studies of Mycobacterium bovis infections in humans and animals in Sweden. J Clin Microbiol (1995) 1.33
Mycobacterium tuberculosis Uganda genotype is the predominant cause of TB in Kampala, Uganda. Int J Tuberc Lung Dis (2008) 1.30
Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays. Infect Immun (1982) 1.26
A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol (2004) 1.25
Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis (2000) 1.23
Structural studies of the O-antigen polysaccharides of Klebsiella O5 and Escherichia coli O8. Carbohydr Res (1985) 1.23
Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain. Infect Immun (1982) 1.21
Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb Pathog (1987) 1.20
Immunochemistry of Salmonella O-antigens: specificity of rabbit antibodies against the O-antigen 4 determinant elicited by whole bacteria and O-antigen 4 specific saccharide-protein conjugates. J Immunol (1979) 1.18
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis (2001) 1.18
The relationship between disease pattern and disease burden by chest radiography, M. tuberculosis Load, and HIV status in patients with pulmonary tuberculosis in Addis Ababa. Infection (2004) 1.16
Studies on the mechanisms of the synergistic effects of ethambutol and other antibacterial drugs on Mycobacterium avium complex. Acta Leprol (1989) 1.16
Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco. avium. Clin Exp Immunol (1996) 1.13
Serovars of Mycobacterium avium complex isolated from patients in Sweden. J Clin Microbiol (1990) 1.13
Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden. Int J Tuberc Lung Dis (2008) 1.13
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. Antimicrob Agents Chemother (1993) 1.13
Salmonella phage glycanases: substrate specificity of the phage P22 endo-rhamnosidase. J Gen Virol (1979) 1.12
Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin. Eur J Clin Microbiol Infect Dis (1988) 1.09
P fimbriated Escherichia coli in adults with acute pyelonephritis. J Infect Dis (1985) 1.06
Outbreak of Mycobacterium tuberculosis infection among captive Asian elephants in a Swedish zoo. Vet Rec (2005) 1.06
Salmonella bacteriophage glycanases: endorhamnosidases of Salmonella typhimurium bacteriophages. J Virol (1979) 1.06
Mycobacterium malmoense: an easily missed pathogen. J Clin Microbiol (1991) 1.05
Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis (2000) 1.04
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tuber Lung Dis (1993) 1.03
Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis. Infect Immun (1981) 1.02
Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis (1992) 1.02
Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux. J Urol (1985) 1.02
The role of pili in the adhesion of Escherichia coli to human urinary tract epithelial cells. Scand J Infect Dis Suppl (1982) 1.01
Association of P and other fimbriae with clinical pyelonephritis in children. Scand J Urol Nephrol (1985) 1.01
The conformation of Salmonella O-antigenic polysaccharide chains of serogroups A, B, and D1 predicted by semi-empirical, Hard-Sphere (HSEA) calculations. Carbohydr Res (1984) 1.01
Ethambutol: a key for Mycobacterium avium complex chemotherapy? Am Rev Respir Dis (1989) 1.01
Periurethral anaerobic microflora of healthy girls. J Clin Microbiol (1979) 1.01
Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis (1995) 0.99
In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex. J Antimicrob Chemother (1989) 0.99
P-fimbriae of pyelonephritogenic Escherichia coli: significance for reflux and renal scarring-a hypothesis. Infection (1983) 0.98
Occurrence of P-fimbriated Escherichia coli in patients with bacteremia. Eur J Clin Microbiol (1985) 0.98
Influence of age on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in hospitalized neonates. J Hosp Infect (1988) 0.97
The use of biochemical markers, serotype and fimbriation in the detection of Escherichia coli clones. J Gen Microbiol (1987) 0.97
Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. Clin Diagn Lab Immunol (1998) 0.96
Immunochemistry of Salmonella O-antigens. Specificity and cross-reactivity of factor O9 serum and of antibodies against tyvelose (Formula: see text) mannose coupled to bovine serum albumin. Int Arch Allergy Appl Immunol (1979) 0.96
P-fimbriae receptors in patients with chronic pyelonephritis. J Urol (1988) 0.95
P-fimbriated Escherichia coli in children with acute cystitis. Acta Paediatr Scand (1987) 0.95
Artificial Salmonella vaccines. Prog Allergy (1983) 0.95